| National Institute on Aging, Industry Launch Partnership, $60 Million Alzheimer’s Disease Neuroimaging Initiative |
|
| October 13, 2004 -- The National Institute on Aging (NIA) in conjunction with other Federal agencies, private companies and organizations today launched a $60 million, 5-year public-private partnership -- the Alzheimer’s Disease Neuroimaging Initiative (ADNI)-- to test whether serial magnetic resonance imaging (MRI), positron emission tomography (PET), other biological markers, and clinical and neuropsychological assessment can be combined to measure the progression of mild cognitive impairment (MCI) and early Alzheimer’s disease (AD). |
| |
| Placing Relative with Dementia into Long-Term Care Facility Does Little to Ease the Emotional Burden of Caregivers |
|
| August 25, 2004 -- A new study shows that caregivers of dementia patients who must make the difficult decision to place their relatives into institutionalized care get no relief from depression and anxiety, and in fact suffer additional emotional trauma following their decision. |
| |
| Donepezil May Have Short-Term Benefit for Mild Cognitive Impairment; More Analyses Needed to Assess Clinical Implications of New Data |
|
| July 18, 2004 -- People with mild cognitive impairment (MCI) taking the drug donepezil were at reduced risk of progressing to Alzheimer's disease (AD) for the first 18 months of a 3-year study when compared with their counterparts on placebo, according to a presentation of preliminary data from a recently completed clinical trial supported by the National Institute on Aging (NIA). |
| |
| Studies Suggest People with Early AD Can Still Learn |
|
| July 2, 2004 -- People who have early stage Alzheimer's disease (AD) could be more capable of learning than previously thought, according to two new studies supported by the National Institute on Aging (NIA). |
| |
| Estrogen-Alone Hormone Therapy Could Increase Risk of Dementia in Older Women |
|
| June 22, 2004 -- Older women using estrogen-alone hormone therapy could be at a slightly greater risk of developing dementia, including Alzheimer’s disease (AD), than women who do not use any menopausal hormone therapy, according to a new report by scientists with the Women’s Health Initiative Memory Study (WHIMS). |
| |
| Diabetes Linked to Increased Risk of Alzheimer's in Long-Term Study |
|
| May 17, 2004 -- Diabetes mellitus was linked to a 65 percent increased risk of developing Alzheimer's disease (AD), appearing to affect some aspects of cognitive function differently than others in a new study supported by the National Institute on Aging (NIA) at the National Institutes of Health. |
| |
| Enhanced Counseling, Support Interventions Slash Long-Term Risk of Depression among AD Caregivers |
|
| May 1, 2004 -- Short-term intensive counseling in conjunction with readily available support can significantly reduce the long-term risk of depression among husbands and wives caring for spouses with Alzheimer's disease. |
| |
| Study Identifies Predictors of Alzheimer's Disease Longevity |
|
| April 6, 2004 -- A new study suggests that assessing several key clinical aspects of the disease soon after diagnosis could help families and physicians better predict long-term survival in individuals with AD. |
| |
| Low Free Testosterone Levels Linked to Alzheimer's Disease in Older Men |
|
| January 26, 2004 -- Older men with lower levels of free, or unbound, testosterone circulating in their bloodstreams could be at higher risk of developing Alzheimer's disease (AD) than their peers, according to research conducted by investigators at the National Institute on Aging (NIA), one of the National Institutes of Health, and others. |
| |
